C

CellVir SAS

10 employees

CellVir develops anti-retrovirals treatments focused on HIV-1 and the viral replication in infected cells.

Basic info

Industry

research services

Sectors

Biotechnology

Date founded

2006

Funding rounds raised

Total raised

$387K

from 1 investors over 1 rounds

C

CellVir SAS raised $387K on June 16, 2008

Investors: institute of Systems and Synthetic Biology, Genopole, CNRS, University of Evry

FAQ